Endothelin receptor antagonists for the treatment of diabetic nephropathy: A meta-analysis and systematic review
出版年份 2020 全文链接
标题
Endothelin receptor antagonists for the treatment of diabetic nephropathy: A meta-analysis and systematic review
作者
关键词
-
出版物
World Journal of Diabetes
Volume 11, Issue 11, Pages 553-566
出版商
Baishideng Publishing Group Inc.
发表日期
2020-11-13
DOI
10.4239/wjd.v11.i11.553
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
- (2020) Frederik C. Enevoldsen et al. Journal of Clinical Medicine
- Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
- (2019) Hiddo J L Heerspink et al. LANCET
- Update on Endothelin Receptor Antagonists in Hypertension
- (2018) Michel Burnier CURRENT HYPERTENSION REPORTS
- DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS
- (2018) Howard Trachtman et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Atrasentan for the treatment of diabetic nephropathy
- (2017) Jesus Egido et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy
- (2016) Margien G.S. Boels et al. DIABETES
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Endothelin-receptor antagonists for diabetic nephropathy: A meta-analysis
- (2015) Wenming Yuan et al. NEPHROLOGY
- Endothelin Receptors and Their Antagonists
- (2015) Janet J. Maguire et al. SEMINARS IN NEPHROLOGY
- Endothelin Blockade in Diabetic Kidney Disease
- (2015) Lidia Anguiano et al. Journal of Clinical Medicine
- The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy
- (2014) D. de Zeeuw et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Therapeutic approaches to diabetic nephropathy—beyond the RAS
- (2014) Beatriz Fernandez-Fernandez et al. Nature Reviews Nephrology
- Endothelin antagonists for diabetic and non-diabetic chronic kidney disease
- (2012) Donald E. Kohan et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Endothelial progenitor cells in relation to endothelin-1 and endothelin receptor blockade: A randomized, controlled trial
- (2012) Christian Jung et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Clinical efficacy of the selective endothelin A receptor antagonist, atrasentan, in patients with diabetes and chronic kidney disease (CKD)
- (2012) Dennis L. Andress et al. LIFE SCIENCES
- The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial
- (2011) A. Rafnsson et al. DIABETOLOGIA
- Addition of Atrasentan to Renin-Angiotensin System Blockade Reduces Albuminuria in Diabetic Nephropathy
- (2011) D. E. Kohan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Potential New Therapeutic Agents for Diabetic Kidney Disease
- (2010) Faruk Turgut et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- DORADO: Opportunity Postponed
- (2010) David J. Webb HYPERTENSION
- Avosentan for Overt Diabetic Nephropathy
- (2010) J. F.E. Mann et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Avosentan Reduces Albumin Excretion in Diabetics with Macroalbuminuria
- (2009) R. R. Wenzel et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
- (2009) Michael A Weber et al. LANCET
- Efficacy and Safety of Darusentan: A Novel Endothelin Receptor Antagonist
- (2008) Benjamin J Epstein ANNALS OF PHARMACOTHERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now